To further explore the effect of DYNLT3 on the growth of breast cancer in vivo, the DYNLT3‐knockdown and control xenograft tumor models were established by subcutaneous injecting the corresponding MCF‐7 cancer cells in nude mice, respectively. Here, DYNLT3 is linked to breast carcinoma.